160 related articles for article (PubMed ID: 22567013)
1. Salivaricin G32, a Homolog of the Prototype Streptococcus pyogenes Nisin-Like Lantibiotic SA-FF22, Produced by the Commensal Species Streptococcus salivarius.
Wescombe PA; Dyet KH; Dierksen KP; Power DA; Jack RW; Burton JP; Inglis MA; Wescombe AL; Tagg JR
Int J Microbiol; 2012; 2012():738503. PubMed ID: 22567013
[TBL] [Abstract][Full Text] [Related]
2. Prevention of streptococcal pharyngitis by anti-Streptococcus pyogenes bacteriocin-like inhibitory substances (BLIS) produced by Streptococcus salivarius.
Tagg JR
Indian J Med Res; 2004 May; 119 Suppl():13-6. PubMed ID: 15232154
[TBL] [Abstract][Full Text] [Related]
3. Salivaricin 9, a new lantibiotic produced by Streptococcus salivarius.
Wescombe PA; Upton M; Renault P; Wirawan RE; Power D; Burton JP; Chilcott CN; Tagg JR
Microbiology (Reading); 2011 May; 157(Pt 5):1290-1299. PubMed ID: 21310787
[TBL] [Abstract][Full Text] [Related]
4. Salivaricin A2 and the novel lantibiotic salivaricin B are encoded at adjacent loci on a 190-kilobase transmissible megaplasmid in the oral probiotic strain Streptococcus salivarius K12.
Hyink O; Wescombe PA; Upton M; Ragland N; Burton JP; Tagg JR
Appl Environ Microbiol; 2007 Feb; 73(4):1107-13. PubMed ID: 17194838
[TBL] [Abstract][Full Text] [Related]
5. Streptococcal Bacteriocin-Like Inhibitory Substances: Some Personal Insights into the Bacteriocin-Like Activities Produced by Streptococci Good and Bad.
Tagg JR
Probiotics Antimicrob Proteins; 2009 Jun; 1(1):60-6. PubMed ID: 26783132
[TBL] [Abstract][Full Text] [Related]
6. Variable characteristics of bacteriocin-producing Streptococcus salivarius strains isolated from Malaysian subjects.
Barbour A; Philip K
PLoS One; 2014; 9(6):e100541. PubMed ID: 24941127
[TBL] [Abstract][Full Text] [Related]
7. Megaplasmids encode differing combinations of lantibiotics in Streptococcus salivarius.
Wescombe PA; Burton JP; Cadieux PA; Klesse NA; Hyink O; Heng NC; Chilcott CN; Reid G; Tagg JR
Antonie Van Leeuwenhoek; 2006 Oct; 90(3):269-80. PubMed ID: 16871420
[TBL] [Abstract][Full Text] [Related]
8. Salivaricin D, a novel intrinsically trypsin-resistant lantibiotic from Streptococcus salivarius 5M6c isolated from a healthy infant.
Birri DJ; Brede DA; Nes IF
Appl Environ Microbiol; 2012 Jan; 78(2):402-10. PubMed ID: 22101034
[TBL] [Abstract][Full Text] [Related]
9. Production of the lantibiotic salivaricin A and its variants by oral streptococci and use of a specific induction assay to detect their presence in human saliva.
Wescombe PA; Upton M; Dierksen KP; Ragland NL; Sivabalan S; Wirawan RE; Inglis MA; Moore CJ; Walker GV; Chilcott CN; Jenkinson HF; Tagg JR
Appl Environ Microbiol; 2006 Feb; 72(2):1459-66. PubMed ID: 16461700
[TBL] [Abstract][Full Text] [Related]
10. Intra- and interspecies signaling between Streptococcus salivarius and Streptococcus pyogenes mediated by SalA and SalA1 lantibiotic peptides.
Upton M; Tagg JR; Wescombe P; Jenkinson HF
J Bacteriol; 2001 Jul; 183(13):3931-8. PubMed ID: 11395456
[TBL] [Abstract][Full Text] [Related]
11. Enhanced production, purification, characterization and mechanism of action of salivaricin 9 lantibiotic produced by Streptococcus salivarius NU10.
Barbour A; Philip K; Muniandy S
PLoS One; 2013; 8(10):e77751. PubMed ID: 24147072
[TBL] [Abstract][Full Text] [Related]
12. Cloning of the gene encoding Streptococcin A-FF22, a novel lantibiotic produced by Streptococcus pyogenes, and determination of its nucleotide sequence.
Hynes WL; Ferretti JJ; Tagg JR
Appl Environ Microbiol; 1993 Jun; 59(6):1969-71. PubMed ID: 8328813
[TBL] [Abstract][Full Text] [Related]
13. Salivaricin E and abundant dextranase activity may contribute to the anti-cariogenic potential of the probiotic candidate Streptococcus salivarius JH.
Walker GV; Heng NCK; Carne A; Tagg JR; Wescombe PA
Microbiology (Reading); 2016 Mar; 162(3):476-486. PubMed ID: 26744310
[TBL] [Abstract][Full Text] [Related]
14. Nucleotide sequence of the streptococcin A-FF22 lantibiotic regulon: model for production of the lantibiotic SA-FF22 by strains of Streptococcus pyogenes.
McLaughlin RE; Ferretti JJ; Hynes WL
FEMS Microbiol Lett; 1999 Jun; 175(2):171-7. PubMed ID: 10386366
[TBL] [Abstract][Full Text] [Related]
15. New insights into the mode of action of the lantibiotic salivaricin B.
Barbour A; Tagg J; Abou-Zied OK; Philip K
Sci Rep; 2016 Aug; 6():31749. PubMed ID: 27526944
[TBL] [Abstract][Full Text] [Related]
16. The mode of action of SA-FF22, a lantibiotic isolated from Streptococcus pyogenes strain FF22.
Jack R; Benz R; Tagg J; Sahl HG
Eur J Biochem; 1994 Jan; 219(1-2):699-705. PubMed ID: 8307035
[TBL] [Abstract][Full Text] [Related]
17. A TaqMan™-based quantitative PCR screening assay for the probiotic Streptococcus salivarius K12 based on the specific detection of its megaplasmid-associated salivaricin B locus.
Reid P; Heng NCK; Hale JD; Krishnan D; Crane J; Tagg JR; Milne TJ
J Microbiol Methods; 2020 Mar; 170():105837. PubMed ID: 31923428
[TBL] [Abstract][Full Text] [Related]
18. Isolation and characterization of the lantibiotic salivaricin A and its structural gene salA from Streptococcus salivarius 20P3.
Ross KF; Ronson CW; Tagg JR
Appl Environ Microbiol; 1993 Jul; 59(7):2014-21. PubMed ID: 8357242
[TBL] [Abstract][Full Text] [Related]
19. Covalent Structure and Bioactivity of the Type AII Lantibiotic Salivaricin A2.
Geng M; Austin F; Shin R; Smith L
Appl Environ Microbiol; 2018 Mar; 84(5):. PubMed ID: 29269497
[TBL] [Abstract][Full Text] [Related]
20. The streptococcal inhibitor of complement (SIC) protects Streptococcus pyogenes from bacteriocin-like inhibitory substance (BLIS) from Streptococcus salivarius.
Minami M; Ohmori D; Tatsuno I; Isaka M; Kawamura Y; Ohta M; Hasegawa T
FEMS Microbiol Lett; 2009 Sep; 298(1):67-73. PubMed ID: 19594623
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
